A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies

COVID-19 survivors develop post-acute sequelae of SARS-CoV-2 (PASC), but the mechanistic basis of PASC-associated lung abnormalities suffers from a lack of longitudinal samples. Mouse-adapted SARS-CoV-2 MA10 produces an acute respiratory distress syndrome (ARDS) in mice similar to humans. To investigate PASC pathogenesis, studies of MA10-infected mice were extended from acute disease through clinical recovery. At 15-120 days post-virus clearance, histologic evaluation identified subpleural lesions containing collagen, proliferative fibroblasts, and chronic inflammation with tertiary lymphoid structures. Longitudinal spatial transcriptional profiling identified global reparative and fibrotic pathways dysregulated in diseased regions, similar to human COVID-19. Populations of alveolar intermediate cells, coupled with focal upregulation of pro-fibrotic markers, were identified in persistently diseased regions. Early intervention with antiviral EIDD-2801 reduced chronic disease, and early anti-fibrotic agent (nintedanib) intervention modified early disease severity. This murine model provides opportunities to identify pathways associated with persistent SARS-CoV-2 pulmonary disease and test countermeasures to ameliorate PASC.

Transboundary introduction of potato-infecting Ralstonia solanacearum in the Andaman Islands revealed by multilocus sequence typing: A potential threat to island agriculture.

Wilting of potato plants with an incidence of 20-30 % was observed for the first time in the agricultural farms of Andaman Islands, India. The infected plants showed wilting syndrome that included downward drooping of leaves, yellowing, and collapse of the entire plants. Characteristic milky-white exudate from the infected stem indicated bacterial etiology of the disease. Upon streaking onto 2, 3, 5 triphenyl-tetrazolium chloride amended nutrient medium, the bacterial exudate yielded characteristic creamy-white, fluidal, irregular colonies with the pink center. Upon inoculation, the randomly picked bacterial colonies, AN_PRSGr and AN_PRSCh, representing the two locations, incited wilt symptoms on one-month-old potato plants. The host range studies revealed that the isolates were pathogenic on tomato and eggplant but non-pathogenic to chili and Solanum torvum (wild eggplant). The 16S rRNA gene sequencing and the Ralstonia-specific PCR test confirmed the identity of AN_PRSGr and AN_PRSCh as Ralstonia solanacearum. Intra-species level classification revealed their identity as strains of race 1, biovar 3, and phylotype-I. Multilocus sequence typing (MLST)-based in-depth sequence alignment for phylogenetic analysis revealed the isolates AN_PRSGr and AN_PRSCh clustered with two mainland race 1/biovar 3/phylotype-I isolates of Kerala, India. However, the allelic profile-based goeBURST-analysis placed them as singletons in the global collection of Ralstonia solanacearum, conforming intra-racial/ intra-phylotype diversity within race 1/biovar3/phylotype-I strains. The molecular characterization.

First 12 patients with coronavirus disease 2019 (COVID-19) in the United States

IntroductionMore than 93,000 cases of coronavirus disease (COVID-19) have been reported worldwide. We describe the epidemiology, clinical course, and virologic characteristics of the first 12 U.S. patients with COVID-19. MethodsWe collected demographic, exposure, and clinical information from 12 patients confirmed by CDC during January 20-February 5, 2020 to have COVID-19. Respiratory, stool, serum, and urine specimens were submitted for SARS-CoV-2 rRT-PCR testing, virus culture, and whole genome sequencing. ResultsAmong the 12 patients, median age was 53 years (range: 21-68); 8 were male, 10 had traveled to China, and two were contacts of patients in this series. Commonly reported signs and symptoms at illness onset were fever (n=7) and cough (n=8). Seven patients were hospitalized with radiographic evidence of pneumonia and demonstrated clinical or laboratory signs of worsening during the second week of illness. Three were treated with the investigational antiviral remdesivir. All patients had SARS-CoV-2 RNA detected in respiratory specimens, typically for 2-3 weeks after illness onset, with lowest rRT-PCR Ct values often detected in the first week. SARS-CoV-2 RNA was detected after reported symptom resolution in seven patients. SARS-CoV-2 was cultured from respiratory specimens, and SARS-CoV-2 RNA was detected in stool from 7/10 patients. ConclusionsIn 12 patients with mild to moderately severe illness, SARS-CoV-2 RNA and viable virus were detected early, and prolonged RNA detection suggests the window for diagnosis is long. Hospitalized patients showed signs of worsening in the second week after illness onset.